Experiences in the introduction of bedaquiline pretomanid linezolid for drug-resistant tuberculosis in Kyrgyzstan [0.03%]
床氨苯砜利奈唑胺在吉尔吉斯斯坦耐多药结核病治疗中的应用经验
B Myrzaliev,M Ahmatov,A Duishekeeva et al.
B Myrzaliev et al.
Settings: In Kyrgyzstan, drug-resistant tuberculosis poses a significant challenge. Recognizing the potential of the BPaL regimen, the World Health Organization recommended its use for selected drug-resistant TB cases und...
Pilot use of a mycolactone-specific lateral flow assay for Buruli ulcer: A case report from Japan [0.03%]
一种用于肉芽肿溃疡的分支杆菌属特异性侧向流动分析法的应用：来自日本的一个案例报告
Yasuhisa Sakakibara,Michio Konishi,Teruo Ueno et al.
Yasuhisa Sakakibara et al.
Buruli ulcer, caused by Mycobacterium (M.) ulcerans, is a neglected tropical disease (NTD) characterized by necrosis of the cutaneous tissue, predominantly affecting the limbs. The pathogenesis of this disease is mainly attributed to mycola...
Nancy Ackam,Abigail Opoku-Boadi,Bernadette Agbavor et al.
Nancy Ackam et al.
Background: Previous studies have demonstrated secondary microbial infection of Buruli ulcer (BUD) lesions before, during and after treatment. However, there is limited data on the bacterial diversity across treatment and...
Costs of non-multidrug-resistant pulmonary tuberculosis and of preventive treatment in Germany - An update [0.03%]
德国肺结核和预防治疗的费用——更新版
Roland Diel,Albert Nienhaus
Roland Diel
Background: Only 4076 new cases of tuberculosis (TB) were reported in Germany in 2022; of those 184 were multidrug-resistant TB (MDR-/RR-TB). Methods: ...
Efficacy and treatment outcome of infected patients with pulmonary Mycobacterium kansasii: A systematic review [0.03%]
卡内斯II肺病感染患者的疗效和治疗结果的系统综述研究
Fatemeh Andalibi,Narjess Bostanghadiri,Nour Amirmozafari et al.
Fatemeh Andalibi et al.
Background: Mycobacterium kansasii (M. kansasii) is a non-tuberculosis bacterium with a highly prevalent that is transferred by aerosols from water and soil resources to the respiratory system. M. kansasii is one of the m...
Antimicrobial susceptibility analysis of isepamicin combination treatments in Mycobacterium abscessus species [0.03%]
异烟胺联合用药对脓肿分枝杆菌的抗菌活性分析
Yukari Kato,Hiroaki Ihara,Satomi Takei et al.
Yukari Kato et al.
This study evaluated the antimicrobial potency of the combination of isepamicin (ISP) for Mycobacterium abscessus species (MABS). 34 clinical MABS strains were isolated from clinical samples. Of them, 11 (32.4 %) were M. abscessus subsp. ab...
Adjuvant surgical treatment of non-tuberculous mycobacterial lung disease in chronic thromboembolic pulmonary hypertension: A first case report [0.03%]
非结核分枝杆菌肺病合并慢性血栓栓塞性肺动脉高压的术后治疗：首例报告
F R Bertuccio,N Baio,S Montini et al.
F R Bertuccio et al.
Pulmonary hypertension (PH) is not considered a known risk factor for non-tuberculous mycobacterial lung disease (NTM-LD), despite that many studies state that incidence is almost equal to other chronic lung diseases. Current standard of ca...
Systematic review: Global host range, case fatality and detection rates of Mycobacterium ulcerans in humans and potential environmental sources [0.03%]
系统评价：Mycobacterium ulcerans的全球宿主范围、人类和潜在环境来源中的病例死亡率及检出率
Serges Tchatchouang,Chris Andre Mbongue Mikangue,Sebastien Kenmoe et al.
Serges Tchatchouang et al.
Fundamental aspects of the epidemiology and ecology of Mycobacterium ulcerans (MU) infections including disease burden, host range, reservoir, intermediate hosts, vector and mode of transmission are poorly understood. Understanding the glob...
Tuberculosis screening for patients on biologic Medications: A Single-Center experience and Society guideline Review, Monroe County, New York, 2018-2021 [0.03%]
纽约奥尼昂塔霍桑医院2018-2021年期间生物制剂使用患者的结核筛查的单一中心经验及学会指南回顾性分析
Tetsuro Maeda,Margaret Connolly,Kelly Thevenet-Morrison et al.
Tetsuro Maeda et al.
Rationale: Biologic medications for immune-mediated inflammatory diseases may increase the risk of tuberculosis (TB) reactivation, but data on screening for TB in low TB prevalence areas are limited. ...
Diagnostic performance of matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOF MS) in bronchoalveolar lavage fluid for pulmonary tuberculosis in HIV-infected patients [0.03%]
MALDI-TOF 质谱技术快速诊断艾滋病患者肺结核价值研究
Mei Zhang,Hongwei Zhang,Benyong Yan et al.
Mei Zhang et al.
Introduction: Pulmonary tuberculosis (PTB) remains a significant health concern, particularly in individuals infected with human immunodeficiency virus (HIV) who are more susceptible to developing active TB disease. Early...